Kallio S, Puurunen J, Ruokonen A, et al. Antimullerian hormone levels decrease in women using combined contraception independently of administration route[J]. Fertil Steril, 2013, 99(5): 1305-1310.
[12]
Su H I,Maas K,Sluss P M, et al. The impact of depot GnRH agonist on AMH levels in healthy reproductive-aged women [J]. J Clin Endocrinol Metab, 2013, 98(12): 1961-1966.
Hadlow N, Longhurst K, McClements A, et al. Variation in antimullerian hormone concentration during the menstrual cycle may change the clinical classification of the ovarian response [J]. Fertil Steril, 2013,99(6):1791-1797.
[13]
Meduri G. Serum anti-Mullerian hormone expression in women with prematureovarian failure [J]. Hum Reprod, 2007, 22(1):117-123.
[3]
Kissell K A, Danaher M R, Schisterman E F, et al. Biological variability in serum anti-Mullerian hormone throughout the menstrual cycle in ovulatory and sporadic anovulatory cycles in eumenorrheic women[J]. Hum Reprod, 2014, 29(8):1764-1772.
[4]
Bungum L, Jacobsson A K, Rosen F, et al. Circadian variation in concentration of anti-Mullerian hormone in regularly menstruating females: relation to age, gonadotrophin and sex steroid levels [J]. Hum Reprod, 2011, 26(3): 678-684.
Van Disseldorp J, Lambalk C B, Kwee J, et al. Comparison of inter- and intra-cycle variability of anti-Mullerian hormone and antral follicle counts [J]. Hum Reprod, 2010, 25(1):221-227.
[15]
Dogan E,Ulukus E C,Okyay E,et al.Retrospective analysis of follicle loss after laparoscopic excision of endometrioma compared with benign nonendometriotic ovarian cysts[J].Int J Gynaecol Obstet,2011,114( 2): 124-127.
[6]
Hagen C P, Aksglaede L, Sorensen K, et al. Serum levels of anti-Miillerian hormone as a marker of ovarian function in 926 healthy females from birth to adulthood and in 172 Turner syndrome patients[J]. J Clin Endocrinol Metab, 2010, 95(11): 5003-5010.
[16]
Ye X P, Yang Y Z, Sun X X. A retrospective analysis of the effect of salpingectomy on serum antiMullerian hormone level and ovarian reserve [J]. Am J Obstet Gynecol, 2015, 212(1): 53e1-53e10.
[17]
Abu Hashim H. Predictors of success of laparoscopic ovarian drilling in women with polycystic ovary syndrome: an evidence-based approach[J].Arch Gynecol Obstet, 2015, 291(1):11-18.
[7]
Bleil M E, Gregorich S E, Adler N E, et al. Race/ethnic disparities in reproductive age: an examination of ovarian reserve estimates across four race/ethnic groups of healthy, regularly cycling women [J]. Fertil Steril, 2014, 101(1):199-207.
[18]
1wase A, Sugita A, Hirokawa W, et al. Anti-Müllerian hormone as a marker of ovarian reserve following chemotherapy in patients with gestational trophoblastic neoplasia [J]. Eur J Obstet Gynecol Reprod Biol, 2013 , 167(2) :194-198.
Thomson R L, Buckley J D, Moran L J, et al. The effect of weight loss on anti-Mullerian hormone levels in overweight and obese women with polycystic ovary syndrome and reproductive impairment [J]. Hum Reprod, 2009, 24(8):1976-1981.
[20]
Codner E, Iniguez G, Hernandez I M, et al. Elevated anti-Mullerian hormone (AMH) and inhibin B levels in prepubertal girls with type 1 diabetes mellitus [J]. Clin Endocrinol, 2011, 74(1): 73-78.
[21]
Van Dorp W, Van den Heuvel-Eibrink M M, De Vries A C, et al. Decreased serum anti-Mullerian hormone levels in girls with newly diagnosed cancer [J]. Hum Reprod, 2014, 29(2):337-342.
[9]
Steiner A Z, Stanczyk F Z, Patel S, et al. Antimullerian hormone and obesity: insights in oral contraceptive users[J]. Contraception, 2010, 81(3): 245-248.
[10]
Nelson S M, Stewart F, Fleming R, et al. Longitudinal assessment of antimullerian hormone during pregnancy-relationship with maternal adiposity, insulin, and adiponectin [J]. Fertil Steril, 2010, 93(4):1356-1358.
[22]
Kuroda K, Uchida T, Nagai S, et al. Elevated serum thyroid-stimulating hormone is associated with decreased anti-Müllerian hormone in infertile women of reproductive age[J]. Assist Reprod Genet, 2015, 23(2):243-247.
[11]
Kallio S, Puurunen J, Ruokonen A, et al. Antimullerian hormone levels decrease in women using combined contraception independently of administration route[J]. Fertil Steril, 2013, 99(5): 1305-1310.
[12]
Su H I,Maas K,Sluss P M, et al. The impact of depot GnRH agonist on AMH levels in healthy reproductive-aged women [J]. J Clin Endocrinol Metab, 2013, 98(12): 1961-1966.
[23]
Walentowicz P, Sadlecki P, Krintus M, et al. Serum anti-Müllerian hormone levels in patients with epithelial ovarian cancer[J].Int J Endocrinol,2013, 2013: 517239-517245.
[24]
Song J Y, Jo H H,Kim M R,et al. Expression of Müllerian inhibiting substance type II receptor and antiproliferative effects of MIS on human cervical cancer[J].Int J Oncology,2012,40(6): 2013-2021.
[13]
Meduri G. Serum anti-Mullerian hormone expression in women with prematureovarian failure [J]. Hum Reprod, 2007, 22(1):117-123.
Dogan E,Ulukus E C,Okyay E,et al.Retrospective analysis of follicle loss after laparoscopic excision of endometrioma compared with benign nonendometriotic ovarian cysts[J].Int J Gynaecol Obstet,2011,114( 2): 124-127.
[16]
Ye X P, Yang Y Z, Sun X X. A retrospective analysis of the effect of salpingectomy on serum antiMullerian hormone level and ovarian reserve [J]. Am J Obstet Gynecol, 2015, 212(1): 53e1-53e10.
[17]
Abu Hashim H. Predictors of success of laparoscopic ovarian drilling in women with polycystic ovary syndrome: an evidence-based approach[J].Arch Gynecol Obstet, 2015, 291(1):11-18.
[18]
1wase A, Sugita A, Hirokawa W, et al. Anti-Müllerian hormone as a marker of ovarian reserve following chemotherapy in patients with gestational trophoblastic neoplasia [J]. Eur J Obstet Gynecol Reprod Biol, 2013 , 167(2) :194-198.
Codner E, Iniguez G, Hernandez I M, et al. Elevated anti-Mullerian hormone (AMH) and inhibin B levels in prepubertal girls with type 1 diabetes mellitus [J]. Clin Endocrinol, 2011, 74(1): 73-78.
[21]
Van Dorp W, Van den Heuvel-Eibrink M M, De Vries A C, et al. Decreased serum anti-Mullerian hormone levels in girls with newly diagnosed cancer [J]. Hum Reprod, 2014, 29(2):337-342.
[22]
Kuroda K, Uchida T, Nagai S, et al. Elevated serum thyroid-stimulating hormone is associated with decreased anti-Müllerian hormone in infertile women of reproductive age[J]. Assist Reprod Genet, 2015, 23(2):243-247.
[23]
Walentowicz P, Sadlecki P, Krintus M, et al. Serum anti-Müllerian hormone levels in patients with epithelial ovarian cancer[J].Int J Endocrinol,2013, 2013: 517239-517245.
[24]
Song J Y, Jo H H,Kim M R,et al. Expression of Müllerian inhibiting substance type II receptor and antiproliferative effects of MIS on human cervical cancer[J].Int J Oncology,2012,40(6): 2013-2021.
2015, Vol. 26 
